|
ZNF75A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.229400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.458600E-01 |
| Normal-vs-Stage2 |
2.653000E-01 |
| Normal-vs-Stage3 |
6.305600E-02 |
| Normal-vs-Stage4 |
4.481200E-01 |
| Stage1-vs-Stage2 |
3.827000E-01 |
| Stage1-vs-Stage3 |
1.051640E-01 |
| Stage1-vs-Stage4 |
6.232400E-01 |
| Stage2-vs-Stage3 |
7.611200E-01 |
| Stage2-vs-Stage4 |
7.225000E-01 |
| Stage3-vs-Stage4 |
4.386200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.867560E-01 |
| Normal-vs-AfricanAmerican |
8.181200E-01 |
| Normal-vs-Asian |
6.892800E-01 |
| Caucasian-vs-AfricanAmerican |
5.515200E-01 |
| Caucasian-vs-Asian |
5.395600E-01 |
| AfricanAmerican-vs-Asian |
5.319800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.430100E-02 |
| Normal-vs-Female |
8.131200E-01 |
| Male-vs-Female |
2.095600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.158600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.138200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.774400E-02 |
| Normal-vs-Age(81-100Yrs) |
4.895800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.232800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.598600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.331200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.562410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.108400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.218400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.198600E-01 |
| Normal-vs-Grade 2 |
9.061400E-01 |
| Normal-vs-Grade 3 |
8.016400E-02 |
| Normal-vs-Grade 4 |
5.060400E-02 |
| Grade 1-vs-Grade 2 |
7.909600E-02 |
| Grade 1-vs-Grade 3 |
1.014040E-02 |
| Grade 1-vs-Grade 4 |
5.318700E-03 |
| Grade 2-vs-Grade 3 |
7.258100E-02 |
| Grade 2-vs-Grade 4 |
4.047500E-02 |
| Grade 3-vs-Grade 4 |
4.175800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.900800E-01 |
| Normal-vs-ccB subtype |
7.648600E-04 |
| ccA subtype-vs-ccB subtype |
3.54799999999766E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.982400E-01 |
| Normal-vs-N1 |
3.548000E-01 |
| N0-vs-N1 |
5.493000E-01 |
|
|
